Therapie des metastasierten Mammakarzinoms – Ist eine Monotherapie machbar?

Publisher： Karger

E-ISSN： 2296-5262|23|3|308-313

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.3, 2000-07, pp. : 308-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Erfahrungen mit Caelyx® in der Therapie des metastasierten Mammakarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 20-25

Karger

Access to resources Recommend Favorite

Palliative Therapie des Mammakarzinoms

By  

Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. : 4-10

Karger

Access to resources Recommend Favorite

Therapiestrategien bei der Behandlung des metastasierten Mammakarzinoms

By  

Oncology Research and Treatment, Vol. 22, Iss. 2, 1999-11 ,pp. : 16-17

Karger

Access to resources Recommend Favorite

Adjuvante Therapie des Mammakarzinoms 2004

By  

Gynäkologisch-geburtshilfliche Rundschau, Vol. 44, Iss. 2, 2004-04 ,pp. : 102-112

Karger

Access to resources Recommend Favorite

Anthrazykline in der adjuvanten Therapie des Mammakarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 7-11

Karger

Access to resources Recommend Favorite